202 related articles for article (PubMed ID: 32675303)
1. Kidney Disease-Associated
Datta S; Kataria R; Zhang JY; Moore S; Petitpas K; Mohamed A; Zahler N; Pollak MR; Olabisi OA
J Am Soc Nephrol; 2020 Sep; 31(9):2083-2096. PubMed ID: 32675303
[TBL] [Abstract][Full Text] [Related]
2. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
O'Toole JF; Schilling W; Kunze D; Madhavan SM; Konieczkowski M; Gu Y; Luo L; Wu Z; Bruggeman LA; Sedor JR
J Am Soc Nephrol; 2018 Mar; 29(3):869-879. PubMed ID: 29180397
[TBL] [Abstract][Full Text] [Related]
3. APOL1 and kidney cell function.
Kumar V; Singhal PC
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F463-F477. PubMed ID: 31241995
[TBL] [Abstract][Full Text] [Related]
4. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
[TBL] [Abstract][Full Text] [Related]
5. APOL1 Kidney Risk Variants Induce Cell Death
Shah SS; Lannon H; Dias L; Zhang JY; Alper SL; Pollak MR; Friedman DJ
J Am Soc Nephrol; 2019 Dec; 30(12):2355-2368. PubMed ID: 31558683
[TBL] [Abstract][Full Text] [Related]
6. APOL1 risk variants and the development of HIV-associated nephropathy.
Goyal R; Singhal PC
FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
[TBL] [Abstract][Full Text] [Related]
7. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.
McCarthy GM; Blasio A; Donovan OG; Schaller LB; Bock-Hughes A; Magraner JM; Suh JH; Tattersfield CF; Stillman IE; Shah SS; Zsengeller ZK; Subramanian B; Friedman DJ; Pollak MR
Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34350953
[TBL] [Abstract][Full Text] [Related]
8. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
9. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
11. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Bruggeman LA; O'Toole JF; Sedor JR
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F1-F8. PubMed ID: 30332315
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.
Gupta N; Waas B; Austin D; De Mazière AM; Kujala P; Stockwell AD; Li T; Yaspan BL; Klumperman J; Scales SJ
Sci Rep; 2024 Feb; 14(1):3765. PubMed ID: 38355600
[TBL] [Abstract][Full Text] [Related]
13. An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.
Li D; Snipes JA; Murea M; Molina AJA; Divers J; Freedman BI; Ma L; Petrovic S
Am J Nephrol; 2020; 51(9):695-704. PubMed ID: 32866949
[TBL] [Abstract][Full Text] [Related]
14. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes.
Bundy JL; Anderson BR; Francescatto L; Garrett ME; Soldano KL; Telen MJ; Davis EE; Ashley-Koch AE
PLoS One; 2019; 14(6):e0217042. PubMed ID: 31158233
[TBL] [Abstract][Full Text] [Related]
16. Protein domains of APOL1 and its risk variants.
Lan X; Wen H; Lederman R; Malhotra A; Mikulak J; Popik W; Skorecki K; Singhal PC
Exp Mol Pathol; 2015 Aug; 99(1):139-44. PubMed ID: 26091559
[TBL] [Abstract][Full Text] [Related]
17. DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.
Chun J; Riella CV; Chung H; Shah SS; Wang M; Magraner JM; Ribas GT; Ribas HT; Zhang JY; Alper SL; Friedman DJ; Pollak MR
J Am Soc Nephrol; 2022 May; 33(5):889-907. PubMed ID: 35232775
[TBL] [Abstract][Full Text] [Related]
18. Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.
Granado D; Müller D; Krausel V; Kruzel-Davila E; Schuberth C; Eschborn M; Wedlich-Söldner R; Skorecki K; Pavenstädt H; Michgehl U; Weide T
J Am Soc Nephrol; 2017 Nov; 28(11):3227-3238. PubMed ID: 28696248
[TBL] [Abstract][Full Text] [Related]
19. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
20. Effect of
Haque S; Patil G; Mishra A; Lan X; Popik W; Malhotra A; Skorecki K; Singhal PC
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28385815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
